Article Versions Notes

Druce I, Tawagi K, Shaw JLV, Ibrahim A, Lochnan H, Ong M. Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists. Current Oncology. 2022; 29(7):4665-4677. https://doi.org/10.3390/curroncol29070370

Druce, Irena, Karine Tawagi, Julie L. V. Shaw, Andrea Ibrahim, Heather Lochnan, and Michael Ong. 2022. "Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists" Current Oncology 29, no. 7: 4665-4677. https://doi.org/10.3390/curroncol29070370

Druce, I., Tawagi, K., Shaw, J. L. V., Ibrahim, A., Lochnan, H., & Ong, M. (2022). Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists. Current Oncology, 29(7), 4665-4677. https://doi.org/10.3390/curroncol29070370